Published in Int J Drug Policy on February 19, 2008
Respondent-driven sampling as Markov chain Monte Carlo. Stat Med (2009) 3.40
SNOWBALL VERSUS RESPONDENT-DRIVEN SAMPLING. Sociol Methodol (2011) 2.56
The context of economic insecurity and its relation to violence and risk factors for HIV among female sex workers in Andhra Pradesh, India. Public Health Rep (2010) 1.85
Factors associated with awareness and utilisation of a community mobilisation intervention for female sex workers in Andhra Pradesh, India. Sex Transm Infect (2010) 1.25
HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities. Curr Opin HIV AIDS (2009) 1.14
What makes a respondent-driven sampling "seed" productive? Example of finding at-risk Massachusetts men who have sex with men. J Urban Health (2010) 1.07
Notes on a cautionary (tall) tale about respondent-driven sampling: a critique of Scott's ethnography. Int J Drug Policy (2008) 1.04
Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Health (2013) 1.02
Ethical considerations in surveys employing respondent-driven sampling. Am J Public Health (2010) 0.94
Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users. Harm Reduct J (2010) 0.92
Candidate change agent identification among men at risk for HIV infection. Soc Sci Med (2012) 0.92
Group sex events amongst non-gay drug users: an understudied risk environment. Int J Drug Policy (2010) 0.91
Ethical considerations in HIV/AIDS biobehavioral surveys that use respondent-driven sampling: illustrations from Lebanon. Am J Public Health (2009) 0.90
Community understanding of Respondent-Driven Sampling in a medical research setting in Uganda: importance for the use of RDS for public health research. Int J Soc Res Methodol (2013) 0.90
Expected ethical competencies of public health professionals and graduate curricula in accredited schools of public health in North America. Am J Public Health (2012) 0.85
Participant and staff experiences in a peer-delivered HIV intervention with injection drug users. J Empir Res Hum Res Ethics (2014) 0.82
Strategies for recruiting injection drug users for HIV prevention services in Delhi, India. Harm Reduct J (2013) 0.80
Investigation of alcohol-related social norms among youth aged 14-17 years in Perth, Western Australia: protocol for a respondent-driven sampling study. BMJ Open (2013) 0.80
The Parasol Protocol: An Implementation Science Study of HIV Continuum of Care Interventions for Gay Men and Transgender Women in Burma/Myanmar. JMIR Res Protoc (2017) 0.78
Lessons learned from respondent-driven sampling recruitment in Nairobi: experiences from the field. BMC Res Notes (2016) 0.77
"We're giving you something so we get something in return": Perspectives on research participation and compensation among people living with HIV who use drugs. Int J Drug Policy (2016) 0.77
A qualitative analysis of peer recruitment pressures in respondent driven sampling: Are risks above the ethical limit? Int J Drug Policy (2015) 0.75
Characteristics and health service utilization in two samples of young injection drug users recruited using direct and referral methods in San Francisco, California. J Alcohol Drug Depend (2013) 0.75
Non-barrier contraceptive use and relation to condom use behaviour by partner type among female sex workers in Andhra Pradesh, India. J Fam Plann Reprod Health Care (2015) 0.75
Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research. BMC Med Ethics (2009) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav (2005) 8.81
Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet (2012) 7.01
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health (2006) 4.85
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
The differential effects of face-to-face and computer interview modes. Am J Public Health (2002) 4.13
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS (2006) 3.55
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29
A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr (2002) 3.20
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis (2011) 3.13
Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications. J Urban Health (2009) 3.00
Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction (2004) 2.97
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med (2010) 2.69
Implementation and analysis of respondent driven sampling: lessons learned from the field. J Urban Health (2006) 2.69
Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep (2007) 2.69
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology (2004) 2.52
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health (2006) 2.42
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr (2002) 2.16
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep (2007) 2.04
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr (2002) 1.97
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One (2012) 1.93
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (2006) 1.88
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction (2007) 1.85
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83
Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr (2007) 1.82
HIV infection, sexual risk behavior, and substance use among Latino gay and bisexual men and transgender persons. Am J Public Health (2008) 1.80
Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr (2002) 1.78
Tuberculosis and illicit drug use: review and update. Clin Infect Dis (2009) 1.76
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. Int J Drug Policy (2006) 1.74
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr (2005) 1.69
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr (2002) 1.68
Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med (2002) 1.66
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol (2013) 1.66
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach. Am J Public Health (2014) 1.62
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.50
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy (2009) 1.45
Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend (2008) 1.41
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction (2007) 1.41
A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat (2002) 1.40
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS (2005) 1.40
Mortality risk among recent-onset injection drug users in five U.S. cities. Subst Use Misuse (2008) 1.39
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica Mex (2007) 1.38
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis (2005) 1.34
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.31
Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS Behav (2007) 1.31
Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam. J Acquir Immune Defic Syndr (2005) 1.31
Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil (2011) 1.30
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction (2003) 1.30
An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav (2013) 1.27
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr (2004) 1.25
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23
Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors. Health Place (2011) 1.23
The Infectious Diseases Society of America emerging infections network: bridging the gap between clinical infectious diseases and public health. Clin Infect Dis (2014) 1.23
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis (2006) 1.23
Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Harm Reduct J (2014) 1.22
Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. J Urban Health (2010) 1.21
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.21
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav (2013) 1.20
High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Sex Transm Dis (2008) 1.19
Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health (2009) 1.19
Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev (2010) 1.19
HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health (2007) 1.19
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res (2007) 1.18
Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health (2007) 1.18
Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin Infect Dis (2003) 1.18
Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J Hepatol (2011) 1.18
Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes. Int J Drug Policy (2008) 1.17
Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend (2004) 1.17
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend (2005) 1.17
Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Subst Use Misuse (2011) 1.16
Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health (2002) 1.15